Jeffrey T L Smith is EVP & Chief Medical Officer of Zymeworks Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zymeworks Inc.
8 Jan 24
3
Zymeworks Inc.
5 Jan 24
4
ALDER BIOPHARMACEUTICALS INC
24 Oct 19
4
ALDER BIOPHARMACEUTICALS INC
18 Sep 19
4
ALDER BIOPHARMACEUTICALS INC
25 Apr 19
4
ALDER BIOPHARMACEUTICALS INC
8 Feb 19
4
ALDER BIOPHARMACEUTICALS INC
4 Dec 18
4
ALDER BIOPHARMACEUTICALS INC
5 Nov 18
4
ALDER BIOPHARMACEUTICALS INC
3 Oct 18
4
ALDER BIOPHARMACEUTICALS INC
6 Sep 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | ZYME Zymeworks | RSU Common Stock | Grant | Acquire A | No | No | 0 | 60,000 | 0.00 | 60,000 |
5 Jan 24 | ZYME Zymeworks | Stock Option Common Stock | Grant | Acquire A | No | No | 10.56 | 90,000 | 950.40 k | 90,000 |